$HIMS Revenue Grows 49% as Subscriber Mix Shifts Upmarket
📊 $Hims & Hers Health Inc.(HIMS)$ : Subscriber Decline Doesn't Tell the Whole Story
A decline in subscribers isn't ideal, but it's happening alongside a much higher price point.
My read is that $HIMS is shifting toward higher-value, higher-revenue subscribers in areas like weight loss, while allowing lower-value customers in ED and hair loss to churn.
That could be a worthwhile trade-off, but it also makes the headline subscriber numbers harder to interpret without more detail on customer mix and revenue per subscriber.
The earnings "miss" also needs to be viewed in the context of management's comments:
"Revenue grew 49% year-over-year, our second consecutive quarter of acceleration, with domestic revenue up 21% year-over-year and international revenue up more than 300% year-over-year.
We delivered those results while intentionally pacing marketing spend ahead of several planned expansions to our platform in the fourth quarter, which we expect will set us up well heading into 2027."
The bigger question is whether the shift toward higher-value subscribers can continue to drive revenue growth and improve customer economics, even if total subscriber counts decline.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
